Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline 1% Cream vs Rhofade in Rosacea
NCT05148689Phase 1Completed
- Start
- Feb 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Mucinex Full Force Nasal Spray in rosacea (3 arms). Primary endpoint: erythema response success at 21 days. Started Feb 2018; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT05148689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148689.